SCOTT STUART: Open Payments
NPI 1528533296 · BURLEY, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$747 in 34 payments from 14 companies in 2025. Trend: 2023 $837 · 2024 $4,271 · 2025 $747
Food & beverage: $526Education: $221
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $356 |
| UCB, Inc. | 4 | $77 |
| ABBVIE INC. | 2 | $57 |
| LEO Pharma Inc. | 2 | $46 |
| Novartis Pharmaceuticals Corporation | 2 | $45 |
| Organon LLC | 2 | $23 |
| Lilly USA, LLC | 1 | $23 |
| Urgo Medical North America, LLC | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Incyte Corporation | 1 | $19 |
Products named: TREMFYA, Bimzelx, SKYRIZI, ANZUPGO, Rhapsido, EBGLYSS, COSENTYX, URGOK2.
Industry payments across ID — which companies pay providers there.
